Adcetris

Seattle Genetics Lymphoma Drug Gets Boxed Warning on Brain Infection Risk
Seattle Genetics Lymphoma Drug Gets Boxed Warning on Brain Infection Risk
Bloomberg
Seattle Genetics
Adcetris
Hodgkin's lymphoma
progressive multifocal leukoencephalopathy
PML
Flag link:
What to Look For With Seattle Genetics in 2012
What to Look For With Seattle Genetics in 2012
Motley Fool
Seattle Genetics
Adcetris
Flag link:
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Bloomberg
Adcetris
Seattle Genetics
Hodgkin's lymphoma
Flag link:
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Bloomberg
Seattle Genetics
Hodgkin's lymphoma
Adcetris
Flag link:
Analyst: Seattle Genetics should outperform forecasts
Analyst: Seattle Genetics should outperform forecasts
bizjournals
Seattle Genetics
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Flag link:
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting
Yahoo/BusinessWire
Seattle Genetics
Millennium
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Flag link:
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Bloomberg
Seattle Genetics
Dendreon
Provenge
Adcetris
lymphoma
Flag link:
Ahead of the Bell: Seattle Genetics shares jump
Ahead of the Bell: Seattle Genetics shares jump
Yahoo/AP
Seattle Genetics
FDA
Adcetris
anaplastic large-cell lymphoma
Flag link:
Seattle Genetics Announces FDA Accelerated Approval of ADCETRIS™ (Brentuximab Vedotin) for Two Indications
Seattle Genetics Announces FDA Accelerated Approval of ADCETRIS™ (Brentuximab Vedotin) for Two Indications
Yahoo/BusinessWire
systemic anaplastic large cell lymphoma
lymphoma
Hodgkin's lymphoma
Adcetris
Flag link:
Biotech Calendar: 2011-12 FDA Drug Approvals
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Flag link:
Biotech Calendar: Key Dates for August
Biotech Calendar: Key Dates for August
TheStreet.com
Alexa
Gilead Sciences
Regeneron
Dendreon
NuPathe
Provenge
Adcetris
Seattle Genetics
Eyelea
Btripla
Zelrix
AZ-004
Flag link:
Seattle Genetics: Adcetris Panel Reconvenes (live blog)
Seattle Genetics: Adcetris Panel Reconvenes (live blog)
TheStreet.com
Seattle Genetics
advisory panels
Adcetris
FDA
anaplastic large-cell lymphoma
Flag link:
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Enhanced Online News
systemic anaplastic large cell lymphoma
Seattle Genetics
Millennium
Adcetris
Flag link:

Pages